Recombinant TNF alpha (Certolizumab Biosimilar) antibody (PE)

Catalog No. ABIN7867452

The Humanized Monoclonal anti-TNF alpha (Certolizumab Biosimilar) antibody is suitable to detect TNF alpha (Certolizumab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant TNF alpha (Certolizumab Biosimilar) antibody (PE) (ABIN7867452)

Target: TNF alpha (Certolizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: PE

Application: Flow Cytometry (FACS)

Product Details

Purpose: PE-conjugated Anti-TNFa(Certolizumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details

Target: TNF alpha (Certolizumab Biosimilar)

Alternative Name: Certolizumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: DIF,TNF-alpha,TNFA,TNFSF2,cachexin,cachectin,TNF?,CDP870, PHA-738144

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P01375